A preliminary study of ECT2 as a novel biomarker for assessing liver fibrosis and prognosis in biliary atresia - Quiz - MDSpire

A preliminary study of ECT2 as a novel biomarker for assessing liver fibrosis and prognosis in biliary atresia

  • By

  • Yuqiang Chen

  • Xin Li

  • Qianhui Yang

  • Yu Meng

  • Alimujiang Abudureyimu

  • Jianghua Zhan

  • June 29, 2026

  • 0 min

Share

Original Source(s)

A preliminary study of ECT2 as a novel biomarker for assessing liver fibrosis and prognosis in biliary atresia

  • by Yuqiang Chen, Xin Li, Qianhui Yang, Yu Meng, Alimujiang Abudureyimu, Jianghua Zhan

  • June 29, 2026

Related Content

Persistently increased frequency of diabetic ketoacidosis in new-onset type 1 diabetes in Polish children: nationwide analysis 2019–2022

Half of states sue over Medicaid work requirements

Immunological and clinical characteristics of severe thrombocytopenia in neonates with Kasabach–Merritt phenomenon